Bold Ideas. Big Impact for Patients.
Over nearly two decades, Third Rock has built more than 70 companies and contributed to 27 approved products touching millions of patients around the world. Behind each is the same differentiated approach: a proven company-building process operating at the intersection of science, medicine, business, and strategy, where transformational science meets operational rigor. We build companies on solid foundations, instilling core values and a commitment to great culture, designed to deliver class-leading benefits to patients and change the health outcomes they can achieve.
Learn more about our newest company, Syremis Therapeutics
Portfolio
